MA44972A - Procédés d'identification de modulateurs du cftr - Google Patents
Procédés d'identification de modulateurs du cftrInfo
- Publication number
- MA44972A MA44972A MA044972A MA44972A MA44972A MA 44972 A MA44972 A MA 44972A MA 044972 A MA044972 A MA 044972A MA 44972 A MA44972 A MA 44972A MA 44972 A MA44972 A MA 44972A
- Authority
- MA
- Morocco
- Prior art keywords
- identification processes
- cftr modulator
- modulator identification
- cftr
- processes
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
- G01N2800/382—Cystic fibrosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662333537P | 2016-05-09 | 2016-05-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA44972A true MA44972A (fr) | 2019-03-20 |
Family
ID=58739383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA044972A MA44972A (fr) | 2016-05-09 | 2017-05-09 | Procédés d'identification de modulateurs du cftr |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20190154661A1 (fr) |
| EP (1) | EP3455624A1 (fr) |
| AU (1) | AU2017264612A1 (fr) |
| CA (1) | CA3023512A1 (fr) |
| MA (1) | MA44972A (fr) |
| WO (1) | WO2017196843A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107922338A (zh) * | 2015-06-02 | 2018-04-17 | 艾伯维公司 | 经取代的吡啶及使用方法 |
| US10548878B2 (en) | 2015-07-24 | 2020-02-04 | Proteostasis Therapeutics, Inc. | Compounds, compositions, and methods of increasing CFTR activity |
| NZ741093A (en) | 2015-10-06 | 2022-12-23 | Proteostasis Therapeutics Inc | Compounds, compositions, and methods for modulating cftr |
| BR112018070747B1 (pt) | 2016-04-07 | 2024-01-09 | Proteostasis Therapeutics, Inc | Átomos de silicone contendo análogos de ivacaftor, composições farmacêuticas e usos terapêuticos |
| EP3472156B1 (fr) | 2016-06-21 | 2023-06-07 | Proteostasis Therapeutics, Inc. | Composés, compositions et procédés pour augmenter l'activité du cftr |
| WO2020006269A1 (fr) | 2018-06-27 | 2020-01-02 | Proteostasis Therapeutics, Inc. | Composés améliorant l'activité du protéasome |
| KR20220019015A (ko) * | 2019-06-10 | 2022-02-15 | 노파르티스 아게 | Cf, copd, 및 기관지확장증 치료를 위한 피리딘 및 피라진 유도체 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2751215A1 (fr) * | 2009-02-02 | 2010-08-05 | Chromocell Corporation | Lignees cellulaires exprimant cftr et procedes d'utilisation associes |
| EP2816034B1 (fr) * | 2010-09-14 | 2018-12-12 | Instytut Biochemii I Biofizyki Polskiej Akademii Nauk | Composés modulateurs d'une protéine cftr mutante et leur utilisation pour le traitement de maladies associées à un dysfonctionnement de la protéine cftr |
| US20160151335A1 (en) | 2013-06-26 | 2016-06-02 | Proteostasis Therapeutics, Inc. | Methods of modulating cftr activity |
| EP3116870A1 (fr) | 2014-03-13 | 2017-01-18 | Proteostasis Therapeutics, Inc. | Composés, compositions et procédés pour augmenter l'activité cftr |
| EP3116501A1 (fr) | 2014-03-13 | 2017-01-18 | Proteostasis Therapeutics, Inc. | Composés, compositions et procédés pour augmenter l'activité du cftr |
| CA2952862A1 (fr) | 2014-06-19 | 2015-12-23 | Proteostasis Therapeutics, Inc. | Composes, compositions et procedes pour augmenter l'activite du cftr |
| NZ741093A (en) | 2015-10-06 | 2022-12-23 | Proteostasis Therapeutics Inc | Compounds, compositions, and methods for modulating cftr |
-
2017
- 2017-05-09 EP EP17724705.3A patent/EP3455624A1/fr not_active Withdrawn
- 2017-05-09 WO PCT/US2017/031754 patent/WO2017196843A1/fr not_active Ceased
- 2017-05-09 CA CA3023512A patent/CA3023512A1/fr not_active Abandoned
- 2017-05-09 US US16/300,219 patent/US20190154661A1/en not_active Abandoned
- 2017-05-09 AU AU2017264612A patent/AU2017264612A1/en not_active Abandoned
- 2017-05-09 MA MA044972A patent/MA44972A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017196843A1 (fr) | 2017-11-16 |
| AU2017264612A1 (en) | 2018-11-22 |
| EP3455624A1 (fr) | 2019-03-20 |
| US20190154661A1 (en) | 2019-05-23 |
| CA3023512A1 (fr) | 2017-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3468725C0 (fr) | Appareil de revêtement de tuyaux | |
| EP3436581A4 (fr) | Procédés d'amplification de transcriptome entier | |
| MA55748A (fr) | Procédés de détection d'aav | |
| EP3430731A4 (fr) | Architecture d'iugw | |
| EP3485773A4 (fr) | Buse d'aspirateur | |
| MA44972A (fr) | Procédés d'identification de modulateurs du cftr | |
| EP3478229A4 (fr) | Dispositif d'ouverture optimale des voies respiratoires. | |
| EP3387023A4 (fr) | Procédés de récupération d'hydrocarbure | |
| PL3311169T3 (pl) | Oznaczenie do identyfikacji modulatorów | |
| EP3507335A4 (fr) | Revêtements polymères | |
| EP3439412A4 (fr) | Procédés de configuration et d'envoi de préambule, et dispositifs associés | |
| EP3474165A4 (fr) | Système de conception d'assistance | |
| EP3443293A4 (fr) | Capteurs d'effort | |
| MA41296A (fr) | Procédés de transdifférenciation et procédés d'utilisation de ceux-ci | |
| EP3558312A4 (fr) | Procédés d'amélioration de la densité vasculaire | |
| EP3556455A4 (fr) | Appareil de production d'urée | |
| EP3371730A4 (fr) | Évaluation automatisée de la qualité d'un échantillon | |
| EP3433383A4 (fr) | Procédés d'amplification quantitative | |
| EP3426262A4 (fr) | Agents de réticulation et procédés associés | |
| MA41298A (fr) | Procédés de marquage de banques codées par de l'adn | |
| EP3512403A4 (fr) | Système d'inspection d'orifice | |
| CH712426C1 (de) | Vorrichtung zur Herstellung eines Granulats. | |
| EP3429690A4 (fr) | Procédés pour moduler keap1 | |
| EP3535061A4 (fr) | Buse microstructurée | |
| EP3431808A4 (fr) | Butée d'arrêt |